Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DOCEHOPE Concentrate for Solution for Infusion 20 mg/ ml - HSA Drug Approval Details

Approvals/HSA/DOCEHOPE Concentrate for Solution for Infusion 20 mg/ ml

Approved

THERAPEUTIC

DOCEHOPE Concentrate for Solution for Infusion 20 mg/ ml

Glenmark Generics S.A.🇸🇬 Health Sciences Authority

Approval Date: Feb 7, 2024
Approval ID: b1de5eeef6e0b385
Company: Glenmark Generics S.A.
Type: Therapeutic

Approval Details

Approval Id: b1de5eeef6e0b385
Drug Name: DOCEHOPE Concentrate for Solution for Infusion 20 mg/ ml
Product Name: DOCEHOPE Concentrate for Solution for Infusion 20 mg/ ml
Approval Number: SIN16943P
Approval Date: 2024-02-07
Registrant: GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INFUSION, SOLUTION CONCENTRATE
Route Of Administration: INTRAVENOUS
Atc Code: L01CD02
Atc Item Name: docetaxel
Pharma Manufacturer Name: GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.
Company Detail Path: /organization/4dcf60d0721da89e/glenmark-pharmaceuticals-singapore-pte-ltd

Active Ingredients

Docetaxel Anhydrous

20 mg / ml

Docetaxel Anhydrous

20 mg / ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 7, 2024

Approval ID

b1de5eeef6e0b385

Type

Therapeutic

Back to HSA Approvals